Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mononegavirales Infections”

664 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 664 results

Not applicableNot Yet RecruitingNCT07338851
What this trial is testing

The Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines

Who this might be right for
PolioMeaslesRubella+2 more
China National Biotec Group Company Limited 600
Early research (Phase 1)Study completedNCT05987072
What this trial is testing

Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.

Who this might be right for
Respiratory Syncytial Virus Infection
Pfizer 12
Not applicableStudy completedNCT05727202
What this trial is testing

Project STARFISH - PRJ0002679

Who this might be right for
SARS-CoV-2 InfectionInfluenza AInfluenza Type B+1 more
Thermo Fisher Scientific, Inc 1,909
Not applicableStudy completedNCT01915394
What this trial is testing

Respiratory Syncytial Virus Infection in Neonatal Intensive Care Units Throughout Turkey: Prospective Multicenter Study (TurkNICU-RSV Trial)

Who this might be right for
Respiratory Syncytial Virus InfectionsInfections, Epidemics
Ankara University 250
Testing effectiveness (Phase 2)Study completedNCT03379675
What this trial is testing

Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus

Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Research & Development, LLC 72
Testing effectiveness (Phase 2)Study completedNCT00861744
What this trial is testing

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Who this might be right for
RubellaMumpsMeasles+1 more
GlaxoSmithKline 1,259
Testing effectiveness (Phase 2)Study completedNCT02873286
What this trial is testing

RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Bavarian Nordic 420
Not applicableStudy completedNCT05494801
What this trial is testing

Natural History, Disease Progression, and Long-Term Neurologic Sequelae of Ebola Virus Disease (EVD) Survivors in PREVAIL III

Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 203
Early research (Phase 1)Study completedNCT01566877
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers

Who this might be right for
Marburg Hemorrhagic Fever
Sarepta Therapeutics, Inc. 40
Post-approval studies (Phase 4)WithdrawnNCT03192371
What this trial is testing

Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children

Who this might be right for
Virus Diseases
GlaxoSmithKline
Early research (Phase 1)Study completedNCT06604767
What this trial is testing

Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionMetapneumovirus InfectionParainfluenzae Virus Infection
Sanofi Pasteur, a Sanofi Company 390
Early research (Phase 1)Study completedNCT01906164
What this trial is testing

Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers

Who this might be right for
Respiratory Syncytial Virus Infections
Alios Biopharma Inc. 101
Not applicableStudy completedNCT02786381
What this trial is testing

Idylla IFV-RSV Panel Clinical Testing

Who this might be right for
Respiratory Tract InfectionsInfluenza, HumanRespiratory Syncytial Virus Infections
Janssen Pharmaceutica N.V., Belgium 213
Early research (Phase 1)Active Not RecruitingNCT06216093
What this trial is testing

Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years

Who this might be right for
Respiratory Syncytial Virus InfectionsRespiratory Syncytial Virus (RSV)
EuBiologics Co.,Ltd 100
Early research (Phase 1)Study completedNCT05281263
What this trial is testing

Phase 1 Study of BLB-201 Vaccine in Healthy Young and Older Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Blue Lake Biotechnology Inc. 30
Early research (Phase 1)Study completedNCT01459198
What this trial is testing

Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT06387511
What this trial is testing

Increasing Measles Vaccination Coverage Through Supplementation With an SQ-LNS Incentive in Children Aged 6-23 Months

Who this might be right for
Immunization CoverageVaccinationNutrition
Alliance for International Medical Action 3,814
Not applicableStudy completedNCT05350735
What this trial is testing

Phone Text Message Reminders on Compliance With Human Rabies Post Exposure Prophylaxis Project

Who this might be right for
Rabies
Washington State University 180
Not applicableUnknownNCT03524417
What this trial is testing

Effect of ERIG Injection on Day 7 After First Dose of Rabies Vaccination to Rabies Immune Response

Who this might be right for
Rabies
Queen Saovabha Memorial Institute 20
Early research (Phase 1)Study completedNCT02370589
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects

Who this might be right for
Ebola
Novavax 230
Next Page